Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Stevens Negus

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Experimental and Clinical Psychopharmacology|July 2, 2019
Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeysJoshua A Lile, Amy R Johnson, Matthew L Banks, et al.
Pharmacology Research & Perspectives|June 29, 2023
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacyEdna J Santos, Nima Nassehi, Eric W Bow, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2024
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in MiceEdna J Santos, Hamid I Akbarali, Eric W Bow, et al.
British Journal of Pharmacology|September 27, 2014
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsRyan A Gregg, Michael H Baumann, John S Partilla, et al.
Pharmacology|June 16, 2007
Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory testsGerald Zernig, Serge H Ahmed, Rudolf N Cardinal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 7, 2014
Rat nucleus accumbens core astrocytes modulate reward and the motivation to self-administer ethanol after abstinenceCecilia Bull, Kelen C C Freitas, Shiping Zou, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceJason M Wiebelhaus, Travis W Grim, Robert A Owens, et al.
ACS Chemical Neuroscience|May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico StudyDelmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.
Psychopharmacology|June 2, 2017
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in ratsE Andrew Townsend, Jennifer E Naylor, S Stevens Negus, et al.
Journal of the Experimental Analysis of Behavior|May 11, 2026
Twenty-five years of simulated demand: A bibliometric and systematic review of hypothetical drug purchase tasksDerek D Reed, Justin C Strickland, Samuel F Acuff, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Experimental and Clinical Psychopharmacology|July 2, 2019
Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeysJoshua A Lile, Amy R Johnson, Matthew L Banks, et al.
Pharmacology Research & Perspectives|June 29, 2023
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacyEdna J Santos, Nima Nassehi, Eric W Bow, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 18, 2024
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in MiceEdna J Santos, Hamid I Akbarali, Eric W Bow, et al.
British Journal of Pharmacology|September 27, 2014
Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in ratsRyan A Gregg, Michael H Baumann, John S Partilla, et al.
Pharmacology|June 16, 2007
Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory testsGerald Zernig, Serge H Ahmed, Rudolf N Cardinal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 7, 2014
Rat nucleus accumbens core astrocytes modulate reward and the motivation to self-administer ethanol after abstinenceCecilia Bull, Kelen C C Freitas, Shiping Zou, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 16, 2014
Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceJason M Wiebelhaus, Travis W Grim, Robert A Owens, et al.
ACS Chemical Neuroscience|May 20, 2025
Transformation of a Potent C9-Substituted Phenylmorphan into MOR Partial Agonists with Improvement of Metabolic Stability: An In Vitro, In Vivo, and In Silico StudyDelmis E Hernandez, Dan Luo, Thomas E Prisinzano, et al.
Psychopharmacology|June 2, 2017
Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in ratsE Andrew Townsend, Jennifer E Naylor, S Stevens Negus, et al.
Journal of the Experimental Analysis of Behavior|May 11, 2026
Twenty-five years of simulated demand: A bibliometric and systematic review of hypothetical drug purchase tasksDerek D Reed, Justin C Strickland, Samuel F Acuff, et al.
Pageof 20